FIS has now submitted its formal response to the HSE consultation on the effectiveness of the Personal Protective Equipment at Work (Amendment) Regulations 2022, including the extension of PPE requirements to “Limb (b) workers”.
The issue has been a longstanding concern for sector, with members highlighting uncertainty around the application of the regulations, responsibility for providing PPE, differing interpretations across the industry, worker-owned PPE and the practical challenges of compliance.
Our response draws on feedback from members and calls for clearer, construction-specific guidance to ensure the regulations are applied consistently and proportionately and we will continue to engage with HSE on the next steps and future guidance. You can read the full response here.
FIS would like to thank members who shared their experiences and contributed to the response.
Health and Safety Toolkit
It is a core objective of FIS to help reduce risk and create a healthier and safer construction environment for all. Our H&S Toolkit aims to support our members work in this area.
See more news likes this
How to deliver a high quality, successful apprenticeship
The road to a quality apprenticeship The road to a quality apprenticeship has been published by Education and Skills Funding Agency (ESFA) to help employers understand the steps involved in delivering high quality, successful apprenticeships in their businesses. A...
CLC launches Construct Zero website
The Construction Leadership Council used the inaugural BMF Sustainability Forum to launch its new Construct Zero website, which will provide a single hub for all information relating to the construction industry’s change programme in the Race to net Zero. Hannah...
Additional funding for training and qualifications
Additional Funding For Training And Qualifications Completed Between 1 August 2020 and 31 March 2021 The FIS Training Group has secured additional funding to support the cost of training and qualifications completed by FIS employer members in scope to CITB. The...



